“Why do some [companies] record that male is a 0 and female is a 1, and others use 1 and 0, and others use M and F. Where is there any competitive advantage to doing that?” says Garry Neil, interim CEO, Transcelerate Biopharma
Ten major drug companies have launched a non-profit organization to create industry data standards. The body, Transcelerate Biopharma, will focus on standards in non-competitive and collaborative aspects of drug trials.
The industry as a whole will save money,
and time to market should improve. It's good to see another industry sector recognizing
that working together on standards can raise the game for everyone. Standards
don't mean uniformity of output. Standards enable excellence by tearing out
pointless duplication, confusion and rework. In this way they promote
competition. Cut Red Tape